Luca Orlando
Hamilton, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Chemical genomics reveals targetable programs of human cancers rooted in pluripotency.
Journal: Cell chemical biology
Published: December 06, 2022
Evidence-based support for phenotypic drug discovery in acute myeloid leukemia.
Journal: Drug discovery today
Published: June 11, 2022
Human Pluripotency Is Initiated and Preserved by a Unique Subset of Founder Cells.
Journal: Cell
Published: September 29, 2018
Induced Pluripotent Stem Cells: Advances in the Quest for Genetic Stability during Reprogramming Process.
Journal: International journal of molecular sciences
Published: July 21, 2017
Brief Report: Human Acute Myeloid Leukemia Reprogramming to Pluripotency Is a Rare Event and Selects for Patient Hematopoietic Cells Devoid of Leukemic Mutations.
Journal: Stem cells (Dayton, Ohio)
Published: February 28, 2017
Sam68 Allows Selective Targeting of Human Cancer Stem Cells.
Journal: Cell chemical biology
Published: February 01, 2017
Derivation of human induced pluripotent stem cells through continued exposure of OCT4-induced plastic human fibroblasts to reprogramming media.
Journal: Stem cell research
Published: June 12, 2015
Maintenance of genomic stability in mouse embryonic stem cells: relevance in aging and disease.
Journal: International journal of molecular sciences
Published: November 13, 2012
Last Updated: 09/26/2026